This Article Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints, Permissions and Rights Citing Articles Citing Articles via Google Scholar Google Scholar Articles by HELLMAN, B. Articles by TÄLJEDAL, I.-B. Search for Related Content PubMed PubMed Citation Articles by HELLMAN, B. Articles by TÄLJEDAL, I.-B.

On the Possible Role of Thiol Groups in the Insulin-Releasing Action of Mercurials, Organic Disulfides, Alkylating Agents, and Sulfonylureas

Department of Histology, University ofUmeå S-901 87 Umeå 6, Sweden

Abstract

The thiol activity of pancreatic islets was spectrophotometrically assayed as the formation of 6-mercaptonicotinic acid from the organic disulfide, 6,6'-dithiodinicotinic acid. Islets containing more than 90% β-cells were microdissected from non-inbred oblob-mice. Comparisons of intact with homogenized islets indicated that the organic disulfide penetrates relatively slowly into the β-cells.

When tested at concentrations known to enhance insulin release, P-chloromercuribenzene-sulfonic acid almost completely blocked the thiol activity of intact islets, whereas no significant effect was observed with iodoacetamide, D-glucose, or glibenclamide. Although glibenclamide had no demonstrable effect on the thiol activity of free L-cysteine, the binding of glibenclamide to serum albumin was decreased by blocking the albumin thiols with azobenzene-2-sulfenyl bromide. The uptake of glibenclamide by pancreatic islets was inhibited by cysteine or reduced glutathione. Cysteine, as well as 6,6'-dithiodinicotinic acid, also seemed to interact negatively with glibenclamide as insulin secretagogue. The results support the hypothesis that organic mercurials and disulfides stimulate insulin release by blocking thiol groups in the β-cell plasma membranes. The thiol groups involved in iodoacetaniideinduced secretion may escape detection by the assay employed, or target groups other than thiols may be involved. The data on glibenclamide are compatible with, but do not unequivocally support, the notion that thiol groups may play a role in sulfonylurea-induced insulin release.

Footnotes

This work was supported by the Swedish Medical Research Council (12x-562) and the Medical Faculty of Umeå.

Received January 15, 1976.